Bomi Song et al., 2022-09-22: Review of 11 benzimidazoles covering preclinical effects, clinical effects and pharmacokinetics; explicitly frames the clinical evidence as limited and the pharmacokinetics as the obstacle.
Although many studies have demonstrated the anti-cancer effects of benzimidazoles, there is limited evidence regarding their effects in clinical settings.
Bomi Song et al., 2022-09-22: Review of 11 benzimidazoles covering preclinical effects, clinical effects and pharmacokinetics; explicitly frames the clinical evidence as limited and the pharmacokinetics as the obstacle. Study type: review. N: not applicable. Country: Korea (Chosun University, Gwangju). Dose: not applicable. Funder: grant '2021Chosun University' (record GrantList). Declared conflicts: 'The authors declare no conflict of interest.' PARTLY because the same paper states that clinical trial evidence is limited and that low bioavailability yields insufficient plasma concentrations. Study type: review.
